These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6092171)

  • 21. Concomitant secretion of calcitonin, beta-endorphin and ACTH from medullary thyroid carcinoma in vivo and in vitro.
    Lamberts SW; Hackeng WH; Visser TJ
    Eur J Cancer Clin Oncol; 1982 Mar; 18(3):253-60. PubMed ID: 6284516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of various neuropeptides on the secretion of proopiomelanocortin-derived peptides by a cultured pituitary adenoma causing Nelson's syndrome.
    Shibasaki T; Masui H
    J Clin Endocrinol Metab; 1982 Nov; 55(5):872-6. PubMed ID: 6126487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular forms of beta-endorphin in ACTH/LPH hypersecretion syndromes in man.
    Sheng SL; Seurin D; Bertagna X; Girard F
    Horm Res; 1984; 20(2):95-9. PubMed ID: 6092255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistical effects of ovine corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) on the release of pro-opiomelanocortin (POMC) related peptides by pituitary adenoma of a patient with Nelson's syndrome in vitro.
    Chan JS; Gaspar L; Iguchi H; Seidah NG; Ling N; Chrétien M
    Clin Invest Med; 1984; 7(4):205-8. PubMed ID: 6335868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pituitary adenomas that caused Cushing's disease or Nelson's syndrome are not responsive to ovine corticotropin-releasing factor in vitro.
    Shibasaki T; Nakahara M; Shizume K; Kiyosawa Y; Suda T; Demura H; Kuwayama A; Kageyama N; Benoit R; Ling N
    J Clin Endocrinol Metab; 1983 Feb; 56(2):414-6. PubMed ID: 6130101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corticotropin/beta-lipotropin biosynthesis, processing, and release in Nelson's syndrome.
    Allen R; Orwoll E; Kammer H; Kendall J
    J Clin Endocrinol Metab; 1981 Oct; 53(4):887-9. PubMed ID: 6270178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secretion of adrenocorticotropin, beta-endorphin and calcitonin by cultured medullary thyroid carcinoma cells. Effects of synthetic corticotropin-releasing factor and lysine vasopressin.
    Oosterom R; Verleun T; Bruining HA; Hackeng WH; Lamberts SW
    Acta Endocrinol (Copenh); 1986 Sep; 113(1):65-72. PubMed ID: 3020852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secretion pattern of pro-opiomelanocortin-derived peptides by a pituitary adenoma from a patient with Cushing's disease.
    Shibasaki T; Masui H; Sato G; Ling N; Guillemin R
    J Clin Endocrinol Metab; 1981 Feb; 52(2):350-3. PubMed ID: 6257745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unrestrained production of proopiomelanocortin (POMC) and its peptide fragments by pituitary corticotroph adenomas in Cushing's disease.
    Bertagna X
    J Steroid Biochem Mol Biol; 1992 Oct; 43(5):379-84. PubMed ID: 1327071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pituitary pro-opiomelanocortin-cell carcinoma occurring in conjunction with a glioblastoma in a patient with Cushing's disease and subsequent Nelson's syndrome.
    Gabrilove JL; Anderson PJ; Halmi NS
    Clin Endocrinol (Oxf); 1986 Aug; 25(2):117-26. PubMed ID: 3024876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromatographic characteristics of pro-opiomelanocortin-derived peptides from the rat transplantable tumour 7315a.
    Morano MI; Estivariz FE
    J Endocrinol; 1987 Mar; 112(3):417-25. PubMed ID: 3031191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The spectrum of ACTH-producing pituitary lesions.
    Lloyd RV; Chandler WF; McKeever PE; Schteingart DE
    Am J Surg Pathol; 1986 Sep; 10(9):618-26. PubMed ID: 2428263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture.
    Yamaji T; Ishibashi M; Teramoto A; Fukushima T
    Acta Endocrinol (Copenh); 1985 Apr; 108(4):456-63. PubMed ID: 2859725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corticotropin releasing factor (CRF): effects on the release of pro-opiomelanocortin (POMC)-related peptides by human anterior pituitary cells in vitro.
    Chan JS; Lu CL; Seidah NG; Chretien M
    Endocrinology; 1982 Oct; 111(4):1388-90. PubMed ID: 6288359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of cyproheptadine, reserpine, and synthetic corticotropin-releasing factor on pituitary glands from patients with Cushing's disease.
    Suda T; Tozawa F; Mouri T; Sasaki A; Shibasaki T; Demura H; Shizume K
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1094-9. PubMed ID: 6302123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple cellular forms of corticotrophs in surgically removed pituitary adenomas and periadenomatous tissue in Cushing's disease.
    Martin R; Cetin Y; Fehm HL; Fahlbusch R; Voigt KH
    Am J Pathol; 1982 Mar; 106(3):332-41. PubMed ID: 6278938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyrotropin-releasing hormone stimulation of adrenocorticotropin production by mouse pituitary tumor cells in culture: possible model for anomalous release of adrenocorticotropin by thyrotropin-releasing hormone in some patients with Cushing's disease and Nelson's syndrome.
    Gershengorn MC; Arevalo CO; Geras E; Rebecchi MJ
    J Clin Invest; 1980 Jun; 65(6):1294-300. PubMed ID: 6251109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: basal concentrations.
    Peterson ME; Orth DN; Halmi NS; Zielinski AC; Davis DR; Chavez FT; Drucker WD
    Endocrinology; 1986 Aug; 119(2):720-30. PubMed ID: 3015556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of ovine corticotropin-releasing hormone and FK 33-824 (met-enkephalin analogue) on the secretions of proopiomelanocortin-derived N-terminal peptide, beta-lipotropin, beta-endorphin and adrenocorticotropin in patients with Addison's disease.
    Sekiya K; Nawata H; Kato K; Motomatsu T; Ibayashi H
    Endocrinol Jpn; 1986 Dec; 33(6):761-8. PubMed ID: 3034555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proopiolipomelanocortin peptides in normal pituitary, pituitary tumor, and plasma of normal and Cushing's horses.
    Wilson MG; Nicholson WE; Holscher MA; Sherrell BJ; Mount CD; Orth DN
    Endocrinology; 1982 Mar; 110(3):941-54. PubMed ID: 6276164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.